Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind trial comparing nalbuphine versus hydroxyzine + salbutamol in dystocia of labor onset
2010-022351-28Phase 3Terminated
- Sponsor
- Hôpital Foch
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nalbuphine in labor dysfunction (2 arms), sponsored by Hôpital Foch. Primary endpoints: Pain VAS at injection and Pain VAS at 1 hour. Started Oct 2010; status: terminated.
02
Drugs
nalbuphine
03
Conditions
labor dysfunction
Beyond the preview
Go deeper on 2010-022351-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022351-28.